[go: up one dir, main page]

Skaarland, 1985 - Google Patents

Morphometric analysis of nuclei in epithelial structures from normal and neoplastic endometrium: a study using the Isaacs cell sampler and Endoscann instruments.

Skaarland, 1985

View PDF
Document ID
3773351854765271679
Author
Skaarland E
Publication year
Publication venue
Journal of clinical pathology

External Links

Snippet

Morphometric analysis of nuclear area and shape in epithelial cells from cytological specimens from 35 patients with normal endometrium and from 20 patients with moderately or well differentiated endometrial adenocarcinoma was performed. The mean nuclear area …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/04—Devices for withdrawing samples in the solid state, e.g. by cutting
    • G01N1/06—Devices for withdrawing samples in the solid state, e.g. by cutting providing a thin slice, e.g. microtome

Similar Documents

Publication Publication Date Title
Haapasalo et al. Volume corrected mitotic index (M/V-INDEX): The standard of mitotic activity in neoplasms
Cohen et al. Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver
Luftig An accurate measurement of the catalase crystal period and its use as an internal marker for electron microscopy
Harpole Jr et al. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.
Sneige et al. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ
Rajput et al. Early detection of oral cancer: PAP and AgNOR staining in brush biopsies
van de Schepop et al. Counting of apoptotic cells: a methodological study in invasive breast cancer
Paez et al. Reliability of the routine cytological diagnosis in bladder cancer
Guarda et al. Inflammatory and lymphoid lesions of the thyroid gland: cytopathology by fine-needle aspiration
Askensten et al. Intratumoral variations in DNA distribution patterns in mammary adenocarcinomas
Skaarland Morphometric analysis of nuclei in epithelial structures from normal and neoplastic endometrium: a study using the Isaacs cell sampler and Endoscann instruments.
Owings Rapid cytologic examination of surgical specimens: a valuable technique in the surgical pathology laboratory
Cherath et al. Evaluation of Masood’s and Modified Masood’s scoring systems in the cytological diagnosis of palpable breast lump aspirates
Hendrickson et al. Toward the development of morphologic criteria for well-differentiated adenocarcinoma of the endometrium
Tosi et al. Gastric dysplasia: a stereological and morphometrical assessment
Srivastava et al. To evaluate the applicability of parameters of cytological grading systems on aspirates of breast carcinoma
Skaarland Nuclear size and shape of epithelial cells from the endometrium: lack of value as a criterion for differentiation between normal, hyperplastic, and malignant conditions.
Montironi et al. Morphometric index of adult renal cell carcinoma: Comparison with the Fuhrman grading system
Klemi et al. Detection of malignancy in endometrium by brush sampling in 1042 symptomatic patients
Van Diest et al. Comparison of light microscopic grading and morphometric features in cytological breast cancer specimens
Lessana‐Leibowitch et al. The diagnosis of cutaneous T‐cell lymphoma by morphometric evaluation of the cellular infiltrate, using semithin sections
Neal et al. The estimation of mean nuclear volume in the diagnosis of breast carcinoma
Layfield et al. Cytological grading of prostatic aspiration biopsy: a comparison with the Gleason grading system
Bosari et al. DNA measurement by image analysis of paraffin-embedded breast carcinoma tissue: A comparative investigation
Pavlakis et al. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16